Neptune Technologies & Bioressources Inc. is Granted Method of Use Patent for Cardiovascular Disease Applications in Europe; EFSA Stamps Final Approval for NKO(R) NOVEL FOOD and PARNUTS Status
10/29/2009 8:27:43 AM
More...
|
Acasti Pharma Completes Offer to Exchange Outstanding Neptune Technologies & Bioressources Inc. Dividend Notes
10/21/2008 2:37:14 PM
More...
|
Neptune Technologies & Bioressources Inc. Reports First Quarter Results
10/10/2008 8:34:28 AM
More...
|
Neptune Technologies & Bioressources Inc. Successfully Completes $2.75 Million Private Placement with 10% Management Participation
10/9/2008 8:42:46 AM
More...
|
Neptune Technologies & Bioressources Inc. Successfully Completes Up to $8.5 Million Debt Financing
9/8/2008 10:30:45 AM
More...
|
Neptune Technologies & Bioressources Inc. Further Advances Its Cardiovascular Pharmaceutical Development Through Its New Operating Subsidiary Acasti Pharma
8/22/2008 8:48:52 AM
More...
|
Neptune Technologies & Bioressources Inc. Dividend Update
8/11/2008 12:16:41 PM
More...
|
Neptune Technologies & Bioressources Inc. Declares Dividend Distribution
7/17/2008 11:22:54 AM
More...
|
Neptune Technologies & Bioressources Inc. Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications
3/27/2008 8:58:56 AM
More...
|
Neptune Technologies & Bioressources Inc. Reports Second Quarter Results and Recent Corporate Highlights
1/14/2008 7:52:28 AM
More...
|
|